PFIZER, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.02 USD | -0.55% |
|
+0.76% | -2.67% |
| May. 09 | HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance | MT |
| May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Presenter SpeechCaroline Roan (Executives)Hello, and thank you for joining. I'm Caroline Roan,...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.18
USD
Average target price
31.94
USD
Spread / Average Target
+13.34%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.67% | 160B | |
| +31.45% | 695B | |
| +26.51% | 568B | |
| -4.66% | 361B | |
| +19.52% | 330B | |
| +3.92% | 283B | |
| +16.70% | 239B | |
| +8.78% | 204B | |
| -7.93% | 198B | |
| +8.83% | 168B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Transcript : Pfizer Inc. - Special Call